Ventricular Assist Device (VAD-C) Practice Exam 2026
– 200 Clinical MCQs with Answers in Bold & Detailed
Explanations | INSTANT PDF DOWNLOAD
Intro
The Ventricular Assist Device (VAD-C) Practice Exam is a comprehensive exam-preparation
resource designed for nurses, advanced practice providers, and critical care clinicians involved in
the management of patients with ventricular assist devices. This exam-style question bank
mirrors real clinical scenarios and competency-based assessments, helping learners strengthen
both theoretical knowledge and bedside decision-making skills related to VAD therapy.
Coverage
This practice exam covers all core and advanced topics required for VAD competency,
including:
VAD physiology and hemodynamics
Types of ventricular assist devices and components
Indications, contraindications, and patient selection
Pre-implant assessment and post-implant care
Anticoagulation and bleeding risk management
Infection prevention and driveline care
VAD alarms, troubleshooting, and emergency response
Hemodynamic monitoring and waveform interpretation
Management of hypotension, arrhythmias, and device failure
Patient education, discharge planning, and long-term care
Q1. The primary purpose of a Ventricular Assist Device (VAD) is to:
A. Replace the heart entirely
B. Support ventricular pumping function
C. Eliminate the need for medications
D. Cure heart failure
,Answer: B
VADs assist one or both ventricles in pumping blood and do not replace the heart.
Q2. Which ventricle is most commonly supported by a VAD?
A. Right ventricle
B. Both ventricles equally
C. Left ventricle
D. Atria
Answer: C
Left Ventricular Assist Devices (LVADs) are most common due to left-sided heart failure
prevalence.
Q3. A continuous-flow VAD differs from a pulsatile-flow VAD because it:
A. Produces a normal pulse
B. Requires no anticoagulation
C. May result in diminished or absent palpable pulse
D. Cannot support long-term use
Answer: C
Continuous-flow devices often reduce arterial pulsatility.
Q4. Which indication is MOST appropriate for VAD implantation?
A. Mild heart failure (NYHA I)
B. End-stage heart failure refractory to medical therapy
C. Acute hypertension
D. Stable coronary artery disease
Answer: B
VADs are used in advanced heart failure when medical therapy is insufficient.
,Q5. “Bridge to transplant” refers to a VAD used to:
A. Replace transplantation
B. Delay transplant indefinitely
C. Support a patient while awaiting heart transplant
D. Provide short-term ICU support only
Answer: C
The VAD maintains circulation until a donor heart becomes available.
Q6. Which parameter is MOST important in assessing VAD flow adequacy?
A. Body temperature
B. Respiratory rate
C. Mean arterial pressure (MAP)
D. Capillary refill time
Answer: C
MAP is the key hemodynamic target in continuous-flow VAD patients.
Q7. The typical target MAP for a continuous-flow LVAD patient is:
A. 40–50 mmHg
B. 50–60 mmHg
C. 70–90 mmHg
D. 100–120 mmHg
Answer: C
Maintaining MAP within this range optimizes device function and reduces complications.
Q8. Which component exits the patient’s body and poses infection risk?
A. Pump housing
B. Inflow cannula
C. Outflow graft
D. Driveline
, Answer: D
The driveline connects the internal pump to the external controller and is a common
infection site.
Q9. Loss of VAD power MOST immediately threatens:
A. Renal function
B. Pulmonary circulation
C. Systemic perfusion
D. Oxygen saturation
Answer: C
Power loss stops pump function, rapidly compromising circulation.
Q10. A VAD patient with dizziness and low MAP is MOST likely experiencing:
A. Device thrombosis
B. Hypovolemia
C. Infection
D. Hypertension
Answer: B
Low preload reduces pump flow, leading to hypotension and symptoms.
Q11. Anticoagulation therapy is required in VAD patients primarily to prevent:
A. Infection
B. Hemorrhage
C. Pump thrombosis and embolic events
D. Hypertension
Answer: C
Blood contact with artificial surfaces increases clotting risk.
– 200 Clinical MCQs with Answers in Bold & Detailed
Explanations | INSTANT PDF DOWNLOAD
Intro
The Ventricular Assist Device (VAD-C) Practice Exam is a comprehensive exam-preparation
resource designed for nurses, advanced practice providers, and critical care clinicians involved in
the management of patients with ventricular assist devices. This exam-style question bank
mirrors real clinical scenarios and competency-based assessments, helping learners strengthen
both theoretical knowledge and bedside decision-making skills related to VAD therapy.
Coverage
This practice exam covers all core and advanced topics required for VAD competency,
including:
VAD physiology and hemodynamics
Types of ventricular assist devices and components
Indications, contraindications, and patient selection
Pre-implant assessment and post-implant care
Anticoagulation and bleeding risk management
Infection prevention and driveline care
VAD alarms, troubleshooting, and emergency response
Hemodynamic monitoring and waveform interpretation
Management of hypotension, arrhythmias, and device failure
Patient education, discharge planning, and long-term care
Q1. The primary purpose of a Ventricular Assist Device (VAD) is to:
A. Replace the heart entirely
B. Support ventricular pumping function
C. Eliminate the need for medications
D. Cure heart failure
,Answer: B
VADs assist one or both ventricles in pumping blood and do not replace the heart.
Q2. Which ventricle is most commonly supported by a VAD?
A. Right ventricle
B. Both ventricles equally
C. Left ventricle
D. Atria
Answer: C
Left Ventricular Assist Devices (LVADs) are most common due to left-sided heart failure
prevalence.
Q3. A continuous-flow VAD differs from a pulsatile-flow VAD because it:
A. Produces a normal pulse
B. Requires no anticoagulation
C. May result in diminished or absent palpable pulse
D. Cannot support long-term use
Answer: C
Continuous-flow devices often reduce arterial pulsatility.
Q4. Which indication is MOST appropriate for VAD implantation?
A. Mild heart failure (NYHA I)
B. End-stage heart failure refractory to medical therapy
C. Acute hypertension
D. Stable coronary artery disease
Answer: B
VADs are used in advanced heart failure when medical therapy is insufficient.
,Q5. “Bridge to transplant” refers to a VAD used to:
A. Replace transplantation
B. Delay transplant indefinitely
C. Support a patient while awaiting heart transplant
D. Provide short-term ICU support only
Answer: C
The VAD maintains circulation until a donor heart becomes available.
Q6. Which parameter is MOST important in assessing VAD flow adequacy?
A. Body temperature
B. Respiratory rate
C. Mean arterial pressure (MAP)
D. Capillary refill time
Answer: C
MAP is the key hemodynamic target in continuous-flow VAD patients.
Q7. The typical target MAP for a continuous-flow LVAD patient is:
A. 40–50 mmHg
B. 50–60 mmHg
C. 70–90 mmHg
D. 100–120 mmHg
Answer: C
Maintaining MAP within this range optimizes device function and reduces complications.
Q8. Which component exits the patient’s body and poses infection risk?
A. Pump housing
B. Inflow cannula
C. Outflow graft
D. Driveline
, Answer: D
The driveline connects the internal pump to the external controller and is a common
infection site.
Q9. Loss of VAD power MOST immediately threatens:
A. Renal function
B. Pulmonary circulation
C. Systemic perfusion
D. Oxygen saturation
Answer: C
Power loss stops pump function, rapidly compromising circulation.
Q10. A VAD patient with dizziness and low MAP is MOST likely experiencing:
A. Device thrombosis
B. Hypovolemia
C. Infection
D. Hypertension
Answer: B
Low preload reduces pump flow, leading to hypotension and symptoms.
Q11. Anticoagulation therapy is required in VAD patients primarily to prevent:
A. Infection
B. Hemorrhage
C. Pump thrombosis and embolic events
D. Hypertension
Answer: C
Blood contact with artificial surfaces increases clotting risk.
